登录 注册 会员服务 联系我们

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults

  • Published:2020-10-05 Issue:7 Volume:21 Page:849-862
  • ISSN:1471-2598
  • Container-title:Expert Opinion on Biological Therapy
  • language:en
  • Short-container-title:Expert Opinion on Biological Therapy

Author:

Goldenson Benjamin H.1ORCID,Goodman Aaron M.2,Ball Edward D.2

Affiliation:

1. Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, La Jolla, California, USA

2. Department of Medicine, Division of Blood and Marrow Transplantation, University of California, San Diego, La Jolla, California, USA

Funder

funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Mastering RNA Interference (RNAi) Delivery – Strategies for Effective Targeting and Gene Silencing;Beyond the Blueprint - Decoding the Elegance of Gene Expression [Working Title];2024-07-12

2. Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients;Cancer Reports;2024-04

3. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice;Experimental Hematology & Oncology;2024-03-01

4. Biological Characteristics and Treatment Progress of Adult Acute Myeloid Leukemia;Advances in Clinical Medicine;2024

5. Pharmacogenomics and Cancer Treatment;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3